LECAP Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
3,217
+1,151
+56% +$553K 0.69% 36
2026
Q1
$1.02M Buy
+2,066
New +$1.12M 0.38% 111
2025
Q2
Sell
-3,091
Closed -$1.54M 391
2025
Q1
$1.54M Sell
3,091
-1,317
-30% -$713K 0.36% 125
2024
Q4
$2.29M Sell
4,408
-358
-8% -$197K 0.62% 41
2024
Q3
$2.95M Sell
4,766
-3,347
-41% -$1.98M 0.64% 44
2024
Q2
$4.49M Buy
+8,113
New +$4.65M 0.97% 6

Other funds holding TMO

LECAP Asset Management's TMO Position: Q2 2026 in Review

LECAP Asset Management increased its Thermo Fisher Scientific (TMO) stake by 56% in Q2 2026, buying an estimated $553K and bringing the position to 3,217 shares worth $1.61M. The position accounts for 0.69% of the portfolio, ranked #36.

LECAP Asset Management first reported a position in TMO in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.49M in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LECAP Asset Management held 3,217 shares of Thermo Fisher Scientific worth $1.61M as of Q2 2026.
  • LECAP Asset Management bought 1,151 Thermo Fisher Scientific shares in Q2 2026, an estimated $553K.
  • Thermo Fisher Scientific made up 0.69% of LECAP Asset Management's portfolio in Q2 2026, its #36 holding.
  • LECAP Asset Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 6 quarters since.
  • LECAP Asset Management's Thermo Fisher Scientific position peaked at $4.49M in Q2 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.